마일스톤

Planaletix was founded with the initial goal of creating an automated business decision platform, later expanding to an ecosystem merging AI, genomics, and blockchain.

The Genaty.ai platform began accepting the $PLTX token for the purchase of DNA analysis packages.

Planaletix announced that 5% of Genaty.ai's monthly revenue would be added to the $PLTX liquidity pool for 12 months.

Planaletix announced its application was approved for the $PLTX token to be listed on the MEXC crypto exchange.